Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results

BACKGROUND: Cell-based therapy may hold promise for treatment of chronic pain. Mesenchymal stem cells (MSCs) are readily available and robust, and their secretion of therapeutic peptides can be enhanced by genetically engineering. We explored the analgesic potential of transplanting bone marrow-deri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hongwei, Fischer, Gregory, Ebert, Allison D, Wu, Hsiang-En, Bai, Xiaowen, Hogan, Quinn H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331376/
https://www.ncbi.nlm.nih.gov/pubmed/25888914
http://dx.doi.org/10.1186/s12990-015-0002-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331376/
https://www.ncbi.nlm.nih.gov/pubmed/25888914
http://dx.doi.org/10.1186/s12990-015-0002-9

Ejemplares similares